Low-Dose Aspirin Use During Pregnancy

被引:399
作者
Porter, T. Flint
Gyamfi-Bannerman, Cynthia
Manuck, Tracy
机构
[1] American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, 20090-6920, DC
关键词
INTRAUTERINE GROWTH RESTRICTION; MATERNAL MEDICATION USE; UTERINE ARTERY DOPPLER; INDUCED HYPERTENSION; DUCTUS-ARTERIOSUS; WEEKS GESTATION; HIGH-RISK; PREVENTION; PREECLAMPSIA; WOMEN;
D O I
10.1097/AOG.0000000000002708
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia. The American College of Obstetricians and Gynecologists issued the Hypertension in Pregnancy Task Force Report recommending daily low-dose aspirin beginning in the late first trimester for women with a history of early-onset preeclampsia and preterm delivery at less than 34 0/7 weeks of gestation, or for women with more than one prior pregnancy complicated by preeclampsia. The U.S. Preventive Services Task Force published a similar guideline, although the list of indications for low-dose aspirin use was more expansive. Daily low-dose aspirin use in pregnancy is considered safe and is associated with a low likelihood of serious maternal, or fetal complications, or both, related to use. The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine support the U.S. Preventive Services Task Force guideline criteria for prevention of preeclampsia. Low-dose aspirin (81 mg/day) prophylaxis is recommended in women at high risk of preeclampsia and should be initiated between 12 weeks and 28 weeks of gestation (optimally before 16 weeks) and continued daily until delivery. Low-dose aspirin prophylaxis should be considered for women with more than one of several moderate risk factors for preeclampsia. Women at risk of preeclampsia are defined based on the presence of one or more high-risk factors (history of preeclampsia, multifetal gestation, renal disease, autoimmune disease, type 1 or type 2 diabetes, and chronic hypertension) or more than one of several moderate-risk factors (first pregnancy, maternal age of 35 years or older, a body mass index greater than 30, family history of preeclampsia, sociodemographic characteristics, and personal history factors). In the absence of high risk factors for preeclampsia, current evidence does not support the use of prophylactic low-dose aspirin for the prevention of early pregnancy loss, fetal growth restriction, stillbirth, or preterm birth.
引用
收藏
页码:E44 / E52
页数:9
相关论文
共 51 条
[1]   Tocolytic Therapy for Acute Preterm Labor [J].
Abramovici, Adi ;
Cantu, Jessica ;
Jenkins, Sheri M. .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2012, 39 (01) :77-+
[2]   Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses [J].
Ahrens, Katherine A. ;
Silver, Robert M. ;
Mumford, Sunni L. ;
Sjaarda, Lindsey A. ;
Perkins, Neil J. ;
Wactawski-Wende, Jean ;
Galai, Noya ;
Townsend, Janet M. ;
Lynch, Anne M. ;
Lesher, Laurie L. ;
Faraggi, David ;
Zarek, Shvetha ;
Schisterman, Enrique F. .
OBSTETRICS AND GYNECOLOGY, 2016, 127 (04) :689-698
[3]  
[Anonymous], 1993, Lancet, V341, P396
[4]  
[Anonymous], 2011, WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia
[5]   Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data [J].
Askie, Lisa M. ;
Duley, Lelia ;
Henderson-Smart, David J. ;
Stewart, Lesley A. .
LANCET, 2007, 369 (9575) :1791-1798
[6]   EFFECT OF LOW-DOSE ASPIRIN ON FETAL AND MATERNAL GENERATION OF THROMBOXANE BY PLATELETS IN WOMEN AT RISK FOR PREGNANCY-INDUCED HYPERTENSION [J].
BENIGNI, A ;
GREGORINI, G ;
FRUSCA, T ;
CHIABRANDO, C ;
BALLERINI, S ;
VALCAMONICO, A ;
ORISIO, S ;
PICCINELLI, A ;
PINCIROLI, V ;
FANELLI, R ;
GASTALDI, A ;
REMUZZI, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (06) :357-362
[7]  
BEROYZ G, 1994, LANCET, V343, P619
[8]   Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis [J].
Bujold, Emmanuel ;
Roberge, Stephanie ;
Lacasse, Yves ;
Bureau, Marc ;
Audibert, Francois ;
Marcoux, Sylvie ;
Forest, Jean-Claude ;
Giguere, Yves .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) :402-414
[9]   Low-dose aspirin to prevent preeclampsia in women at high risk [J].
Caritis, S ;
Sibai, B ;
Hauth, J ;
Lindheimer, MD ;
Klebanoff, M ;
Thom, E ;
VanDorsten, P ;
Landon, M ;
Paul, R ;
Miodovnik, M ;
Meis, P ;
Thurnau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :701-705
[10]   SUPPRESSION OF THROMBOXANE-A2 BUT NOT OF SYSTEMIC PROSTACYCLIN BY CONTROLLED-RELEASE ASPIRIN [J].
CLARKE, RJ ;
MAYO, G ;
PRICE, P ;
FITZGERALD, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) :1137-1141